85 related articles for article (PubMed ID: 29316737)
1. The Effect of Lipopolysaccharide on Noxa Expression Is Mediated through IRF1, 3, and 7.
Piya S; Kim TH
J Microbiol Biotechnol; 2018 Mar; 28(3):491-497. PubMed ID: 29316737
[TBL] [Abstract][Full Text] [Related]
2. Suppression of IRF4 by IRF1, 3, and 7 in Noxa expression is a necessary event for IFN-γ-mediated tumor elimination.
Piya S; Moon AR; Song PI; Hiscott J; Lin R; Seol DW; Kim TH
Mol Cancer Res; 2011 Oct; 9(10):1356-65. PubMed ID: 21816905
[TBL] [Abstract][Full Text] [Related]
3. Interferons alpha and gamma induce p53-dependent and p53-independent apoptosis, respectively.
Porta C; Hadj-Slimane R; Nejmeddine M; Pampin M; Tovey MG; Espert L; Alvarez S; Chelbi-Alix MK
Oncogene; 2005 Jan; 24(4):605-15. PubMed ID: 15580300
[TBL] [Abstract][Full Text] [Related]
4. Single-stranded RNA viruses inactivate the transcriptional activity of p53 but induce NOXA-dependent apoptosis via post-translational modifications of IRF-1, IRF-3 and CREB.
Lallemand C; Blanchard B; Palmieri M; Lebon P; May E; Tovey MG
Oncogene; 2007 Jan; 26(3):328-38. PubMed ID: 16832344
[TBL] [Abstract][Full Text] [Related]
5. Restoration of IRF1-dependent anticancer effects by MEK inhibition in human cancer cells.
AbuSara N; Razavi S; Derwish L; Komatsu Y; Licursi M; Hirasawa K
Cancer Lett; 2015 Feb; 357(2):575-81. PubMed ID: 25497010
[TBL] [Abstract][Full Text] [Related]
6. Noxa induces apoptosis in oncogene-expressing cells through catch-and-release mechanism operating between Puma and Mcl-1.
Nakajima W; Tanaka N
Biochem Biophys Res Commun; 2011 Oct; 413(4):643-8. PubMed ID: 21945433
[TBL] [Abstract][Full Text] [Related]
7. p53-independent Noxa induction by cisplatin is regulated by ATF3/ATF4 in head and neck squamous cell carcinoma cells.
Sharma K; Vu TT; Cook W; Naseri M; Zhan K; Nakajima W; Harada H
Mol Oncol; 2018 Jun; 12(6):788-798. PubMed ID: 29352505
[TBL] [Abstract][Full Text] [Related]
8. Expression of the immune regulator tripartite-motif 21 is controlled by IFN regulatory factors.
Sjöstrand M; Ambrosi A; Brauner S; Sullivan J; Malin S; Kuchroo VK; Espinosa A; Wahren-Herlenius M
J Immunol; 2013 Oct; 191(7):3753-63. PubMed ID: 23975864
[TBL] [Abstract][Full Text] [Related]
9. Interferon regulatory factor signaling in autoimmune disease.
Matta B; Song S; Li D; Barnes BJ
Cytokine; 2017 Oct; 98():15-26. PubMed ID: 28283223
[TBL] [Abstract][Full Text] [Related]
10. Krüppel-Like Factor 4 and Its Activator APTO-253 Induce NOXA-Mediated, p53-Independent Apoptosis in Triple-Negative Breast Cancer Cells.
Nakajima W; Miyazaki K; Asano Y; Kubota S; Tanaka N
Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33918002
[TBL] [Abstract][Full Text] [Related]
11. Cooperative contributions of interferon regulatory factor 1 (IRF1) and IRF8 to interferon-γ-mediated cytotoxic effects on oligodendroglial progenitor cells.
Horiuchi M; Itoh A; Pleasure D; Ozato K; Itoh T
J Neuroinflammation; 2011 Jan; 8():8. PubMed ID: 21261980
[TBL] [Abstract][Full Text] [Related]
12. Effects of IRF1 and IFN-β interaction on the M1 polarization of macrophages and its antitumor function.
Xie C; Liu C; Wu B; Lin Y; Ma T; Xiong H; Wang Q; Li Z; Ma C; Tu Z
Int J Mol Med; 2016 Jul; 38(1):148-60. PubMed ID: 27176664
[TBL] [Abstract][Full Text] [Related]
13. Reciprocal regulation of the Il9 locus by counteracting activities of transcription factors IRF1 and IRF4.
Campos Carrascosa L; Klein M; Kitagawa Y; Lückel C; Marini F; König A; Guralnik A; Raifer H; Hagner-Benes S; Rädler D; Böck A; Kang C; Lohoff M; Garn H; Schaub B; Berberich-Siebelt F; Sakaguchi S; Bopp T; Huber M
Nat Commun; 2017 May; 8():15366. PubMed ID: 28497800
[TBL] [Abstract][Full Text] [Related]
14. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with repression of interferon regulatory factor-1.
Zekri AR; Moharram RA; Mohamed WS; Bahnassy AA; Alam El-Din HM; Abo-Shadi MM; Zayed NA; El-Magzangy H; Abdel-Aziz AO; Esmat G
Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):450-6. PubMed ID: 19858727
[TBL] [Abstract][Full Text] [Related]
15. BAL1/ARTD9 represses the anti-proliferative and pro-apoptotic IFNγ-STAT1-IRF1-p53 axis in diffuse large B-cell lymphoma.
Camicia R; Bachmann SB; Winkler HC; Beer M; Tinguely M; Haralambieva E; Hassa PO
J Cell Sci; 2013 May; 126(Pt 9):1969-80. PubMed ID: 23487038
[TBL] [Abstract][Full Text] [Related]
16. Batf2/Irf1 induces inflammatory responses in classically activated macrophages, lipopolysaccharides, and mycobacterial infection.
Roy S; Guler R; Parihar SP; Schmeier S; Kaczkowski B; Nishimura H; Shin JW; Negishi Y; Ozturk M; Hurdayal R; Kubosaki A; Kimura Y; de Hoon MJ; Hayashizaki Y; Brombacher F; Suzuki H
J Immunol; 2015 Jun; 194(12):6035-44. PubMed ID: 25957166
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin hypersensitivity of testicular germ cell tumors is determined by high constitutive Noxa levels mediated by Oct-4.
Gutekunst M; Mueller T; Weilbacher A; Dengler MA; Bedke J; Kruck S; Oren M; Aulitzky WE; van der Kuip H
Cancer Res; 2013 Mar; 73(5):1460-9. PubMed ID: 23302226
[TBL] [Abstract][Full Text] [Related]
18. AICAR induces Bax/Bak-dependent apoptosis through upregulation of the BH3-only proteins Bim and Noxa in mouse embryonic fibroblasts.
González-Gironès DM; Moncunill-Massaguer C; Iglesias-Serret D; Cosialls AM; Pérez-Perarnau A; Palmeri CM; Rubio-Patiño C; Villunger A; Pons G; Gil J
Apoptosis; 2013 Aug; 18(8):1008-16. PubMed ID: 23605481
[TBL] [Abstract][Full Text] [Related]
19. MG132 induced apoptosis is associated with p53-independent induction of pro-apoptotic Noxa and transcriptional activity of beta-catenin.
Jüllig M; Zhang WV; Ferreira A; Stott NS
Apoptosis; 2006 Apr; 11(4):627-41. PubMed ID: 16673057
[TBL] [Abstract][Full Text] [Related]
20. Reversal of Mutant KRAS-Mediated Apoptosis Resistance by Concurrent Noxa/Bik Induction and Bcl-2/Bcl-xL Antagonism in Colon Cancer Cells.
Okamoto K; Zaanan A; Kawakami H; Huang S; Sinicrope FA
Mol Cancer Res; 2015 Apr; 13(4):659-69. PubMed ID: 25548100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
